A 62-year-old man with a 15-year history of idiopathic pulmonary fibrosis presents with worsening dyspnea and exercise intolerance. HRCT chest shows bilateral lower lobe predominant reticular opacities with traction bronchiectasis and honeycombing. Pulmonary function tests reveal FVC 52% predicted and DLCO 35% predicted. Which of the following cardiac findings on echocardiography would you most expect in this patient?

Explanation

## Pathophysiology of Pulmonary Fibrosis and Secondary Pulmonary Hypertension Idiopathic pulmonary fibrosis (IPF) is characterized by progressive lung parenchymal destruction, leading to: ### Mechanism of Right Heart Involvement 1. **Chronic hypoxemia** from impaired gas exchange due to fibrotic destruction 2. **Pulmonary vascular remodeling** secondary to chronic hypoxia and inflammation 3. **Progressive pulmonary hypertension** (PH) development 4. **Right ventricular adaptation** → eccentric hypertrophy → eventual dilatation and dysfunction **Key Point:** The HRCT findings of honeycombing, traction bronchiectasis, and lower lobe predominance are pathognomonic for usual interstitial pneumonia (UIP) pattern, the hallmark of IPF. ### Expected Echocardiographic Findings **High-Yield:** Patients with advanced IPF (FVC 52%, DLCO 35% — both significantly reduced) develop secondary pulmonary hypertension, manifesting as: - **Right ventricular dilatation** (RV:LV ratio >0.9) - **Elevated tricuspid regurgitation velocity** (TRV >2.8 m/s suggests RV systolic pressure >35 mmHg) - **Reduced RV systolic function** (TAPSE <16 mm, S' wave <10 cm/s) - **Flattened interventricular septum** during systole **Clinical Pearl:** The degree of PH correlates with disease severity and prognosis in IPF. RV dysfunction is an independent predictor of mortality. ### Why Option 0 Is Correct The combination of: - Severe restrictive physiology (FVC 52% predicted) - Markedly reduced DLCO (35% predicted) → chronic hypoxemia - UIP pattern on HRCT (honeycombing, traction bronchiectasis) ...inevitably leads to secondary pulmonary hypertension and RV dysfunction. ## Why Each Distractor Is Wrong | Distractor | Reason | |---|---| | **Option 1** | LV dilatation with reduced EF suggests primary left heart disease (cardiomyopathy, ischemia) or advanced biventricular failure. IPF causes *secondary* PH affecting the RV first; LV dysfunction occurs only in end-stage disease or concurrent cardiac pathology. The FVC and DLCO values point to pulmonary, not cardiac, primary disease. | | **Option 2** | Restrictive mitral inflow with normal PA pressures is inconsistent with the severe DLCO reduction (35%) and advanced fibrosis. IPF with this degree of impairment will have developed PH; normal PA pressures would suggest early disease or a non-fibrotic diagnosis. | | **Option 3** | Hypertrophic cardiomyopathy with SAM and LVOT obstruction is a primary myocardial disorder unrelated to pulmonary fibrosis. There is no clinical or radiological clue suggesting HCM; this is a distractor testing whether students confuse primary cardiac disease with secondary cardiac effects of lung disease. | **Mnemonic:** **IPF → PH → RV** (Idiopathic Pulmonary Fibrosis → Pulmonary Hypertension → Right Ventricular dysfunction) **Warning:** Do not confuse secondary PH (RV-predominant) with primary left heart disease. The HRCT pattern and PFT values are diagnostic of IPF; the cardiac consequence is RV, not LV, dysfunction. [cite:Harrison 21e Ch 297]